IRCT20200130046311N1已完成未知
Comparative evaluation of the response rate based on tricoscopic criteria in patients with severe alopecia areata treated with diphencyprone with or without intralesional platelet rich plasma
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •A patient with alopecia areata whose definitive diagnosis was made on clinical or histological basis and their involvement was severe (> 50% scalp area and less than 100%).
- •Positive response to test with 2% Diphen Ciprone solution
排除标准
- •Patients with alopecia totalis or universalis
- •Receive any systemic treatment during the last 6 months
- •Children under 18 years
- •Pregnant and lactating women
- •Immunosuppressed patient
- •patient with platelet dysfunction
- •patient with a history of injecting steroids on the site over the past month
- •Fever, systemic infection and local infection at the injection site
研究者
相似试验
已完成
2 期
Evaluating the relationship between response to an olfactory stress test and level of cognitive decline in older adults.ALZHEIMER'S DISEASEACTRN12617000273381Dr. Peter Schofield279
已完成
不适用
A nationwide questionnaire survey on late effects among Dutch childhood cancer survivors: which invitation strategy to use?CancerISRCTN84711754Academic Medical Center (AMC) (Netherlands)750
招募中
2 期
Determining the association of response rate to Intravitreal injection of bevacizumab and macular vessel density in patients with diabetic macular edema using optical coherence tomography angiography (OCT-A)IRCT20220416054548N1Esfahan University of Medical Sciences70
招募中
1 期
Investigation of complete-response rate of intralesional immunotherapy with Candida antigen for the treatment of molluscum contagiosumMolluscum contagiosumIRCT20180411039265N2Mashhad University of Medical Sciences40
进行中（未招募）
不适用
Assessment of the early efficacy response rate of leflunomide according to the initial dosing regimen in the treatment of naive - DMARD early RA-patients. - LEADERPatients with a diagnosis of early active rhematoid arthritis in the previous 6 months, naive of previous treatment by DMARD and who need to be treated by DMARD.MedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2007-000886-40-ITsanofi-aventis Groupe200